Cargando…

Use of Cardiac Contractility Modulation in an Older Patient with Non-Ischemic Dilated Cardiomyopathy: A Case Report

Cardiac contractility modulation (CCM) is a novel device-based therapy used in patients with HFrEF. CCM therapy is associated with an improvement in exercise tolerance, increased quality of life, reduced HF hospitalizations, and reverse remodelling of the left ventricle in patients with HFrEF. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manganelli, Gianvito, Fiorentino, Antonio, Ceravolo, Gianluca, Minichiello, Stefana, Bianchino, Giuseppe, Bellizzi, Gennaro, Pacileo, Giuseppe, Masarone, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628722/ https://www.ncbi.nlm.nih.gov/pubmed/34842623 http://dx.doi.org/10.3390/clinpract11040098

Ejemplares similares

Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report
por: Masarone, Daniele, et al.
Publicado: (2022)

First human implant of the cardiac contractility modulation in patient with dilated cardiomyopathy–related laminopathy
por: D’Onofrio, Antonio, et al.
Publicado: (2023)

Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
por: Masarone, Daniele, et al.
Publicado: (2018)

A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy
por: Mazzaccara, Cristina, et al.
Publicado: (2018)

The Effects of Device-Based Cardiac Contractility Modulation Therapy on Left Ventricle Global Longitudinal Strain and Myocardial Mechano-Energetic Efficiency in Patients with Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2022)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease
por: Limongelli, Giuseppe, et al.
Publicado: (2018)

Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic Cardiomyopathy
por: Limongelli, Giuseppe, et al.
Publicado: (2019)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
por: Lu, Danbo, et al.
Publicado: (2019)

The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy
por: Raucci, Frank J., et al.
Publicado: (2020)

The Role of Echocardiography in the Management of Heart Transplant Recipients
por: Masarone, Daniele, et al.
Publicado: (2021)

Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes
por: Vikhorev, Petr G., et al.
Publicado: (2017)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
por: Masarone, Daniele, et al.
Publicado: (2019)

Pathophysiology-Based Management of Acute Heart Failure
por: Falco, Luigi, et al.
Publicado: (2023)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Cardiac-Specific Overexpression of Catalytically Inactive Corin Reduces Edema, Contractile Dysfunction, and Death in Mice with Dilated Cardiomyopathy
por: Tripathi, Ranjana, et al.
Publicado: (2019)

Author Correction: Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes
por: Vikhorev, Petr G., et al.
Publicado: (2018)

The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy
por: Makarewich, Catherine A, et al.
Publicado: (2018)

Evaluation of the pharmacotherapeutic impact on contractility recovery in patients with newly diagnosed, acute onset dilated cardiomyopathy
por: Orszulak, Michal, et al.
Publicado: (2023)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Metabolic Approaches for the Treatment of Dilated Cardiomyopathy
por: Spoladore, Roberto, et al.
Publicado: (2023)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Left ventricle restoration in end stage ischemic dilated cardiomyopathy
por: Jonjev, Z
Publicado: (2013)

Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy
por: Ziebolz, Dirk, et al.
Publicado: (2021)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
por: Canu, Marjorie, et al.
Publicado: (2021)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
por: Zhou, Mei, et al.
Publicado: (2023)

Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy
por: Slart, R. H. J. A., et al.
Publicado: (2010)

Clinical and echocardiographic differences in patients with dilated cardiomyopathy in the frame depending preserved left ventricular contractile reserve
por: Peric, V, et al.
Publicado: (2013)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
por: Masarone, Daniele, et al.
Publicado: (2021)

Intermittent Hypoxia Triggers Early Cardiac Remodeling and Contractile Dysfunction in the Time‐Course of Ischemic Cardiomyopathy in Rats
por: Bourdier, Guillaume, et al.
Publicado: (2020)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
por: Contaldi, Carla, et al.
Publicado: (2023)

Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o04lv114oe0pp9qbcfl579ee6n